tiprankstipranks
MindBio’s Promising Results in Depression Treatment
Company Announcements

MindBio’s Promising Results in Depression Treatment

Story Highlights

Mindbio Therapeutics Corp. (TSE:MBIO) has released an update.

Stay Ahead of the Market:

MindBio Therapeutics Corp. reports a 72% reduction in depression severity among patients six months after using their lead drug, MB22001, in clinical trials. The company is pioneering the use of microdoses of psychedelic medicines for take-home use, aiming to transform the treatment of depressive disorders.

For further insights into TSE:MBIO stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App

Latest News Feed

More Articles